Fidelity Investments
SPRB icon

Fidelity Investments’s Spruce Biosciences SPRB Stock Holding History

Fidelity Investments’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$174K Buy
3,589
+3,246
+946% +$164K ﹤0.01% 3764
2026
Q2 		$18.5K Buy
+343
New +$19.2K ﹤0.01% 4695
2024
Q2 		– Sell
-1
Closed -$81 – 5684
2024
Q1 		$81 Buy
+1
New +$254 ﹤0.01% 4991
2023
Q4 		– Hold
0
– -$82 – 5691
2023
Q3 		– Hold
0
– – – 4881
2023
Q2 		– Sell
-1
Closed -$111 – 5626
2023
Q1 		$111 Buy
+1
New +$186 ﹤0.01% 4892
2022
Q4 		– Sell
-6
Closed -$570 – 5623
2022
Q3 		$570 Hold
6
– – ﹤0.01% 4779
2022
Q2 		$722 Sell
6
-87
-94% -$11.1K ﹤0.01% 4812
2022
Q1 		$14K Sell
93
-1,434
-94% -$267K ﹤0.01% 4135
2021
Q4 		$511K Sell
1,527
-11,160
-88% -$3.32M ﹤0.01% 2795
2021
Q3 		$5.72M Sell
12,687
-3,122
-20% -$1.96M ﹤0.01% 2321
2021
Q2 		$13.3M Sell
15,809
-126
-0.8% -$134K ﹤0.01% 2001
2021
Q1 		$19.8M Buy
15,935
+11
+0.1% +$16.9K ﹤0.01% 1810
2020
Q4 		$29M Buy
+15,924
New +$26.4M ﹤0.01% 1546

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Carlyle Group
Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return
Quinn Opportunity Partners
Quinn Opportunity Partners Charlottesville, Virginia $1.85B AUM 1.27% 1-Year Est. Return
DMKJ
David M. Knott Jr $183M AUM 73.23% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Persistent Asset Partners
Persistent Asset Partners Hong Kong $362M AUM 191.92% 1-Year Est. Return

Fidelity Investments's SPRB Position: Q3 2026 in Review

Fidelity Investments increased its Spruce Biosciences (SPRB) stake by 946% in Q3 2026, buying an estimated $164K and bringing the position to 3,589 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #3764.

Fidelity Investments first reported a position in SPRB in Q4 2020 and has held it in 12 quarters since. The position peaked at $29M in Q4 2020. 40 funds tracked by Wall St. Rank hold SPRB as of Q3 2026.

  • Fidelity Investments held 3,589 shares of Spruce Biosciences worth $174K as of Q3 2026.
  • Fidelity Investments bought 3,246 Spruce Biosciences shares in Q3 2026, an estimated $164K.
  • Spruce Biosciences made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #3764 holding.
  • Fidelity Investments first reported a position in Spruce Biosciences in Q4 2020 and has held it in 12 quarters since.
  • Fidelity Investments's Spruce Biosciences position peaked at $29M in Q4 2020.
  • 40 funds tracked by Wall St. Rank held Spruce Biosciences as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.